Simulations Plus Inc (SLP) 7.96 $SLP Simulations Plus

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Simulations Plus Inc (SLP) 7.96 $SLP

Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
BusinessWire - 1 hr 35 mins ago
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly cash dividend of $0.05 per share to its shareholders. This cash dividend will be distributed on Thursday, August 18, 2016, to shareholders of record as of Thursday, August 11, 2016.
SLP: 7.96 (-0.05)

Simulations Plus Releases ADMET Predictor(TM) Version 8.0
BusinessWire - 1 hr 35 mins ago
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has released Version 8.0 of its best-in-class ADMET Predictor(TM) molecular property prediction software.
SLP: 7.96 (-0.05)

Simulations Plus (SLP) in Focus: Stock Adds 5.9% in Session
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 7:35AM CDT
Simulations Plus, Inc. (SLP) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
SLP: 7.96 (-0.05), EXA: 14.41 (-0.19)

Simulations Plus Reports Preliminary Revenues for Third Quarter FY2016
BusinessWire - Tue Jun 07, 7:30AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the third quarter of its fiscal year 2016, the period ended May 31, 2016 (3QFY16).
SLP: 7.96 (-0.05)

Simulations Plus to Present at LD Micro Invitational on June 7, 2016
BusinessWire - Thu Jun 02, 7:30AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all phases of pharmaceutical discovery and development, announced that Walt Woltosz, chief executive officer, will present at the 6th Annual LD Micro Invitational investor conference on Tuesday, June 7, 2016, at 11:30 a.m. PT. The conference will be held June 7-9, 2016, at the Luxe Sunset Bel Air Hotel in Los Angeles.
SLP: 7.96 (-0.05)

Simulations Plus (SLP): Moving Average Crossover Alert
Zacks Equity Research - Zacks Investment Research - Mon May 09, 9:12AM CDT
Simulations Plus, Inc. (SLP) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
SLP: 7.96 (-0.05)

Simulations Plus Releases DDDPlus Version 5.0
BusinessWire - Thu Apr 14, 7:30AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has released Version 5.0 of its DDDPlus(TM) in vitro dissolution experiment simulation software.
SLP: 7.96 (-0.05)

Simulations Plus posts 2Q profit
Automated Insights - Wed Apr 13, 3:06PM CDT
LANCASTER, Calif. (AP) _ Simulations Plus Inc. (SLP) on Wednesday reported fiscal second-quarter profit of $1.1 million.
SLP: 7.96 (-0.05)

Simulations Plus Reports Second Quarter FY2016 Financial Results
BusinessWire - Wed Apr 13, 3:01PM CDT
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all phases of pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, today reported financial results for its second quarter of fiscal year 2016, the period ended February 29, 2016 (2QFY16).
SLP: 7.96 (-0.05)

Simulations Plus Releases KIWI Version 1.5
BusinessWire - Tue Mar 15, 2:00PM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its Buffalo division (Cognigen Corporation) has released Version 1.5 of KIWI(TM), a private cloud-based platform to efficiently and consistently organize, process, evaluate, and communicate modeling and simulation results.
SLP: 7.96 (-0.05)

Simulations Plus Reports Record Preliminary Revenues for Second Quarter FY2016
BusinessWire - Thu Mar 10, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the second quarter of its fiscal year 2016, the period ended February 29, 2016 (2QFY16).
SLP: 7.96 (-0.05)

Simulations Plus (SLP): Strong Industry, Solid Earnings Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 7:37AM CST
Simulations Plus is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective
SLP: 7.96 (-0.05)

Shares of SLP Up 17.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 01, 5:21PM CST
SmarTrend identified an Uptrend for Simulations Plus (NASDAQ:SLP) on December 29th, 2015 at $9.62. In approximately 1 month, Simulations Plus has returned 17.42% as of today's recent price of $11.29.
SLP: 7.96 (-0.05)

Simulations Plus to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference
BusinessWire - Tue Jan 26, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that Walt Woltosz, Chairman and Chief Executive Officer, will provide a company overview at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference on Thursday, February 11, 2016, at 8:30 a.m. EST. The conference will be held at the Convene Conference Center at 730 Third Avenue in New York City. Simulations Plus management will be available during the day for one-on-one meetings.
SLP: 7.96 (-0.05)

Uptrend Call Working As Simulations Plus Stock Rises 17.6% (SLP)
Comtex SmarTrend(R) - Mon Jan 25, 12:02PM CST
SmarTrend identified an Uptrend for Simulations Plus (NASDAQ:SLP) on December 29th, 2015 at $9.62. In approximately 4 weeks, Simulations Plus has returned 17.63% as of today's recent price of $11.31.
SLP: 7.96 (-0.05)

Simulations Plus Reports First Quarter FY2016 Financial Results
BusinessWire - Thu Jan 14, 3:01PM CST
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all phases of pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, today reported financial results for its first quarter of fiscal year 2016, the period ended November 30, 2015 (1QFY16).
SLP: 7.96 (-0.05)

New Information Reveals Opportunity in Volatility - Featured Research on Simulations Plus, Olympic Steel, Unity Bancorp, and Shore Bancshares
ACCESSWIRE - Mon Jan 11, 7:20AM CST
NEW YORK, NY / ACCESSWIRE / January 11, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Simulations Plus Inc. (NASDAQ: SLP), Olympic Steel Inc. (NASDAQ: ZEUS), Unity Bancorp Inc. (NASDAQ: UNTY) and Shore Bancshares Inc. (NASDAQ: SHBI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
SLP: 7.96 (-0.05), SHBI: 11.66 (-0.10), ZEUS: 28.28 (-0.38), UNTY: 12.62 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 460

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 261

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 349

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 443

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 213

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 448

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 191

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 348

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 430

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 280

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading

Top 5 Most Recently Viewed Articles

Robinhood's Rise: A Shift from Meme Stock to Financial Powerhouse

Updated Category News Views 246

Robinhood's Transformation in the Financial Landscape Recently, Robinhood Markets announced a significant upgrade to its stock, with Barclays analyst Benjamin Budish raising the rating from Underweight to Equal-Weight. This adjustment also includes an increase in the price target from $18 to $20, indicating a positive outlook for the company. A Seasoned Player in the...

Continue Reading
Transforming Global Education: Italy and Nigeria's Bold Initiative

Updated Category News Views 271

Italy and Nigeria Launch a $5 Billion Education Campaign In a collaborative effort, Italy and Nigeria, in partnership with the Global Partnership for Education (GPE), have launched a bold campaign aimed at transforming education for 750 million children worldwide. This ambitious initiative was announced at a high-profile event during the United Nations General Assembly,...

Continue Reading
KBR Secures Critical Engineering Contract for LNG Project

Updated Category News Views 248

KBR's New Engineering Milestone in LNG Development HOUSTON — KBR announced today that it has secured a major contract from INPEX Masela Ltd. for front-end engineering design (FEED) work on the Abadi LNG project in Indonesia. Understanding the Abadi LNG Project The Abadi LNG project is poised to make significant contributions to Indonesia’s energy sector, with a peak...

Continue Reading
Investors Urged to Act Following Class Action Against CAPR

Updated Category News Views 209

Investors Encouraged to Take Action Against Capricor Therapeutics Bragar Eagel & Squire, P.C. is reaching out to investors who may have suffered losses due to recent developments with Capricor Therapeutics (CAPR). Individuals who purchased or acquired securities during the specified class period are urged to connect with the firm's litigation partner, Brandon Walker, to...

Continue Reading
Celebrating Dr. Kristina K. Roberts as a Pinnacle Lifetime Member

Updated Category News Views 218

Dr. Kristina K. Roberts Recognized for Excellence in Mental Health In a significant acknowledgment of her contributions to the field of mental health care, Dr. Kristina K. Roberts, Psy.D. has been honored as a Pinnacle Lifetime Member by The Inner Circle. This prestigious recognition illustrates her unwavering commitment and profound impact on the lives of her patients....

Continue Reading